Furthermore, studies have shown that the combination of LDHA inhibitors with anti-PD-1 therapy can significantly reduce the tumor volume in a mouse orthotopic BCa model compared to the use of anti-PD-1 therapy alone [46]. The gene discussed is LDHA; the disease is neoplasm.